This page includes the latest FDA filings for Nx Development Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Medexus Pharma, Inc., NX Development Corp | Prescription Medication | 2024-05-07 |
Medexus Pharma, Inc., NX Development Corp | Prescription Medication | 2024-01-13 |
Medexus Pharma, Inc., NX Development Corp | Prescription Medication | 2022-04-28 |
NX DEVELOPMENT CORP | Prescription Medication | 2021-03-05 |
NX DEVELOPMENT CORP | Prescription Medication | 2019-03-14 |
NX DEVELOPMENT CORP | GLEOLAN | 2018-03-14 |
NCAGE Code | 7JRU6 | NX DEVELOPMENT CORP. |
CAGE Code | 7JRU6 | NX DEVELOPMENT CORP. |
S.A.M. Registration | 7JRU6 [79994320] | NX DEVELOPMENT CORP. |
DUNS | 079994320 | NX Development Corp. |
SEC | 0001635942 | NX Development Corp. of DELAWARE |